Back3D Global Biotech Overview

3D Global Biotech Intangible Assets

3D Global Biotech's intangible assets is $66M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$66.10M
↓ 17.81% YoYΔ $-14.32M vs prior year quarter

Peer trimmed avg / median

Loading

3D Global Biotech Intangible Assets History

Loading

3D Global Biotech vs. peers: Intangible Assets Comparison

Loading

3D Global Biotech Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

3D Global Biotech (6808.TWO) FAQ

The latest intangible assets for 6808.TWO is $66M as of June 2026. That compares with $80M in the prior-year period — down 17.8% year over year. Investors often review this figure alongside 3D Global Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6808.TWO's intangible assets moved from $80M to $66M — a 17.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 3D Global Biotech's operating scale or balance-sheet position.

A intangible assets figure of $66M for 6808.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6808.TWO's intangible assets ($66M), review year-over-year change from $80M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 3D Global Biotech's intangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.